We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pervasis to Begin Phase III Trial of Its Hemodialysis Treatment
Pervasis to Begin Phase III Trial of Its Hemodialysis Treatment
February 3, 2010
Pervasis Therapeutics is starting a Phase III study of its hemodialysis access graft failure treatment Vascugel now that the FDA has agreed to permit a
special protocol assessment for it.